ExodusPoint Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,231
Closed -$501K 3074
2021
Q1
$501K Sell
4,231
-829
-16% -$98.1K 0.01% 1358
2020
Q4
$598K Buy
+5,060
New +$588K 0.01% 1143
2020
Q1
Sell
-2,233
Closed -$260K 1900
2019
Q4
$260K Buy
+2,233
New +$259K ﹤0.01% 1221
2019
Q3
Sell
-6,862
Closed -$654K 1793
2019
Q2
$654K Buy
+6,862
New +$646K 0.03% 377

ExodusPoint Capital Management's CBPO Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 4,231 shares — an estimated $501K sold.

ExodusPoint Capital Management first reported a position in CBPO in Q2 2019 and held it in 4 quarters. The position peaked at $654K in Q2 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • ExodusPoint Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 4,231 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $501K.
  • ExodusPoint Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2019 and held it in 4 quarters.
  • ExodusPoint Capital Management's China Biologic Products Holdings, Inc. position peaked at $654K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.